PNC FINANCIAL SERVICES GROUP, INC.

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 713676 Pittsburgh, PA

Position in DNTH

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$3,135,250

+$1,601,373 QoQ

Shares Held

37,360

+0.4% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 99.64668094218415.ToString("F0")% Shared 0.3533190578158458.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $99,745,852 across 264 Biotechnology names. DNTH ranks #7 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	71,942	$32,124,978
2	REGN	Regeneron Pharmaceuticals, Inc.	18,226	$14,082,131
3	TECH	BIO-TECHNE Corp	93,722	$4,897,909
4	ALNY	Alnylam Pharmaceuticals, Inc.	12,322	$4,076,976
5	MRNA	Moderna, Inc.	69,883	$3,550,054
6	INCY	Incyte Corp	33,976	$3,197,817
7	DNTH	Dianthus Therapeutics, Inc. /DE/ This page	37,360	$3,135,250
8	ARGX	Argenx SE	3,796	$2,772,027

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,135,250	37,360	+0.4%	Shares	Defined	2026-05-08
2025-12-31	$1,533,877	37,221	0.0%	Shares	Defined	2026-02-06
2025-09-30	$1,464,645	37,221	+0.3%	Shares	Defined	2025-11-07
2025-06-30	$691,173	37,100	0.0%	Shares	Defined	2025-08-08
2025-03-31	$672,994	37,100	0.0%	Shares	Defined	2025-05-09
2024-12-31	$808,780	37,100	0.0%	Shares	Defined	2025-02-07
2024-09-30	$1,015,798	37,100	0.0%	Shares	Defined	2024-11-08
2024-06-30	$960,148	37,100	0.0%	Shares	Defined	2024-08-09
2024-03-31	$1,113,000	37,100	—	Shares	Defined	2024-05-10
No filing history on record for this holder in this stock.